UBS Initiates Aetna with a "Buy" Rating (AET)

UBS Initiates Aetna with a “Buy” Rating (AET)


UBS reported on Friday that it has initiated coverage of healthcare benefits company, Aetna Inc. (AET).

The firm has begun coverage of AET with a “Buy” rating and $63 price target. This price target suggests a 13% increase from the stock’s current price of $54.60.

Analysts have given the company a “Buy” rating based on the Coventry Healthcare acquisition which will help the company reach its 10% EPS compounded annual growth rate target.

Aetna shares were mostly flat during premarket trading Friday. The stock has increased 9% in the past year.

The Bottom Line
Shares of Aetna Inc. (AET) have a 1.47% yield, based on Thursday’s closing price of $54.60.

Aetna Inc. (AET) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today